We are live on ! Find out more
SEI Investments

SEI Investments Portfolio holdings

AUM $108B
1-Year Est. Return 26.14%
This Fund
S&P 500
This Quarter Est. Return
-14.32%
1 Year Est. Return
+26.14%
3 Year Est. Return
+80.41%
5 Year Est. Return
+95.44%
10 Year Est. Return
+382.16%
AUM
$46.3B
AUM Growth
-$3.44B
Cap. Flow
+$4.84B
Cap. Flow %
10.46%
Top 10 Hldgs %
18.01%
Holding
2,797
New
228
Increased
1,461
Reduced
759
Closed
156

Sector Composition

Rank Sector Weight
1 Technology 16.8%
2 Healthcare 11.34%
3 Financials 9.6%
4 Consumer Discretionary 8.2%
5 Industrials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECL icon
226
Ecolab
ECL
$79.2B
$42.9M 0.09%
279,115
+12,733
+5% +$2.11M
SQM icon
227
Sociedad Química y Minera de Chile
SQM
$19.2B
$42.5M 0.09%
509,278
+69,509
+16% +$6.12M
BRK.B icon
228
Berkshire Hathaway Class B
BRK.B
$1.1T
$42.5M 0.09%
155,563
-68,341
-31% -$21.4M
MS icon
229
Morgan Stanley
MS
$320B
$42.4M 0.09%
556,183
+125,539
+29% +$10.3M
ADP icon
230
Automatic Data Processing
ADP
$112B
$42.4M 0.09%
202,003
+67,780
+50% +$14.9M
MCO icon
231
Moody's
MCO
$84.2B
$42.3M 0.09%
155,133
+16,463
+12% +$4.93M
HUM icon
232
Humana
HUM
$43.5B
$42.1M 0.09%
91,644
+28,842
+46% +$12.8M
ASND icon
233
Ascendis Pharma A/S
ASND
$16.6B
$42M 0.09%
451,801
+7,242
+2% +$683K
IWS icon
234
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
$41.7M 0.09%
410,079
+276,099
+206% +$30.9M
RJF icon
235
Raymond James Financial
RJF
$33.8B
$41.6M 0.09%
465,203
+96,983
+26% +$9.5M
SBUX icon
236
Starbucks
SBUX
$118B
$41.3M 0.09%
541,831
+447,792
+476% +$34.4M
PM icon
237
Philip Morris
PM
$314B
$41.2M 0.09%
417,799
+35,858
+9% +$3.66M
DUK icon
238
Duke Energy
DUK
$101B
$41.2M 0.09%
383,400
+42,906
+13% +$4.72M
HPQ icon
239
HP
HPQ
$25.9B
$41.1M 0.09%
1,253,769
-462,708
-27% -$17M
WAB icon
240
Wabtec
WAB
$49.6B
$41.1M 0.09%
500,203
+40,793
+9% +$3.64M
WST icon
241
West Pharmaceutical
WST
$23.5B
$40.9M 0.09%
134,845
+1,231
+0.9% +$401K
IDXX icon
242
Idexx Laboratories
IDXX
$45B
$40.7M 0.09%
116,384
+7,829
+7% +$3.19M
CRL icon
243
Charles River Laboratories
CRL
$11.5B
$40.7M 0.09%
190,271
+95,402
+101% +$23.3M
DHI icon
244
D.R. Horton
DHI
$41.7B
$40.7M 0.09%
613,158
+313,134
+104% +$22M
VRSK icon
245
Verisk Analytics
VRSK
$28.9B
$40.5M 0.09%
233,998
+33,636
+17% +$6.27M
GLOB icon
246
Globant
GLOB
$1.66B
$40.5M 0.09%
232,568
-41,248
-15% -$8.4M
GGG icon
247
Graco
GGG
$13.2B
$40.4M 0.09%
680,702
+17,204
+3% +$1.08M
C icon
248
Citigroup
C
$215B
$40.1M 0.09%
868,400
+252,899
+41% +$12.7M
ALGN icon
249
Align Technology
ALGN
$12.8B
$39.3M 0.08%
166,168
+30,153
+22% +$9.26M
USB icon
250
US Bancorp
USB
$98.9B
$38.9M 0.08%
844,932
+219,584
+35% +$11M

Similar funds

SEI Investments's Q2 2022 Portfolio in Review

As of Q2 2022, SEI Investments held 2,797 positions worth $46.3B, down 6.9% from $49.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

SEI Investments deployed $4.84B of net new capital in Q2 2022, opening 228 new positions and adding to 1,461 existing holdings. Its largest new stake was Aspen Technology Inc: 152,022 shares worth $27.9M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $154M trimmed.

  • SEI Investments's largest Q2 2022 buy was Aspen Technology Inc: 152,022 shares worth $27.9M.
  • SEI Investments added most to iShares National Muni Bond ETF in Q2 2022, an estimated $147M increase.
  • SEI Investments's biggest Q2 2022 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $154M.
  • SEI Investments fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $35.2M.
  • SEI Investments's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2022.
  • SEI Investments opened 228 new positions and closed 156 in Q2 2022.
  • SEI Investments's portfolio value fell 6.9% quarter-over-quarter to $46.3B.

Based on SEI Investments's 13F filing for Q2 2022, filed 15 Aug 2022.